Shareholders of Biomet Inc. are scheduled to vote June 8 on the company’s $10.9 billion acquisition by several private equity firms. The special shareholder meeting will be in
Shareholders holding at least 75 percent of the company’s common stock must vote in favor of the merger for it to be approved.
In December, Biomet agreed to be bought by LVB Acquisition LLC; Goldman, Sachs & Co.; Kohlberg Kravis Roberts; and Texas Pacific Group. If the merger is approved, shareholders will receive $44 a share in cash.
Please enable JavaScript to view this content.